8.4 C
London
Saturday, February 22, 2025
HomeMarketsEurope Markets

Europe Markets

spot_img

Fabhalta | European Medicines Agency (EMA)

OverviewFabhalta is a medicine used in adults with paroxysmal nocturnal haemoglobinuria (PNH) to treat haemolytic anaemia.PNH is a disease in which the excessive...

Qaialdo | European Medicines Agency (EMA)

OverviewQaialdo is a medicine used to manage refractory oedema (swelling due to fluid build-up that does not respond to standard treatments) associated with...

Pluvicto | European Medicines Agency (EMA)

OverviewPluvicto is a medicine used to treat cancer of the prostate (a gland of the male reproductive system). It is used when the...

Zoely | European Medicines Agency (EMA)

OverviewThis is a summary of the European public assessment report (EPAR) for Zoely. It explains how the Committee for Medicinal Products for Human...

Obgemsa | European Medicines Agency (EMA)

OverviewObgemsa is a medicine used to treat adults with overactive bladder syndrome (OAB). It is used to treat symptoms of the condition such...

Neupro | European Medicines Agency (EMA)

OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...

Avamys | European Medicines Agency (EMA)

OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img